title: ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology.
abstract: Enteral nutrition (EN) by means of oral nutritional supplements (ONS) and tube feeding (TF) offers the possibility of increasing or ensuring nutrient intake in cases where normal food intake is inadequate. These guidelines are intended to give evidence-based recommendations for the use of ONS and TF in cancer patients. They were developed by an interdisciplinary expert group in accordance with officially accepted standards, are based on all relevant publications since 1985 and were discussed and accepted in a consensus conference. Undernutrition and cachexia occur frequently in cancer patients and are indicators of poor prognosis. EN should be started if undernutrition already exists or if food intake is markedly reduced for more than 7-10 days. Standard formulae are recommended for EN. Nutritional needs generally are comparable to non-cancer subjects. In cachectic patients metabolic modulators such as progestins, steroids and possibly eicosapentaenoic acid may help to improve nutritional status. EN is indicated preoperatively for 5-7 days in cancer patients undergoing major abdominal surgery. During radiotherapy of head/neck and gastrointestinal regions dietary counselling and ONS prevent weight loss and interruption of radiotherapy. Routine EN is not indicated during (high-dose) chemotherapy.
authors.affiliation: Department of Medical Oncology, Tumor Biology Center, Albert-Ludwigs-Universität, Freiburg, Germany. arends@tumorbio.uni-freiburg.de
authors.forename: J
authors.initials: J
authors.lastname: Arends
authors.forename: G
authors.initials: G
authors.lastname: Bodoky
authors.forename: F
authors.initials: F
authors.lastname: Bozzetti
authors.forename: K
authors.initials: K
authors.lastname: Fearon
authors.forename: M
authors.initials: M
authors.lastname: Muscaritoli
authors.forename: G
authors.initials: G
authors.lastname: Selga
authors.forename: M A E
authors.initials: MA
authors.lastname: van Bokhorst-de van der Schueren
authors.forename: M
authors.initials: M
authors.lastname: von Meyenfeldt
authors.forename: G
authors.initials: G
authors.lastname: Zürcher
authors.forename: R
authors.initials: R
authors.lastname: Fietkau
authors.forename: E
authors.initials: E
authors.lastname: Aulbert
authors.forename: B
authors.initials: B
authors.lastname: Frick
authors.forename: M
authors.initials: M
authors.lastname: Holm
authors.forename: M
authors.initials: M
authors.lastname: Kneba
authors.forename: H J
authors.initials: HJ
authors.lastname: Mestrom
authors.forename: A
authors.initials: A
authors.lastname: Zander
mesh_terms: D002100:Cachexia / Q000209:etiology / Q000628:therapy*; D004750:Enteral Nutrition / Q000379:methods / Q000592:standards*; D005060:Europe; D006801:Humans; D044342:Malnutrition / Q000209:etiology / Q000628:therapy*; D008495:Medical Oncology / Q000592:standards*; D009369:Neoplasms / Q000150:complications; D010818:Practice Patterns, Physicians'